{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:53:50Z","timestamp":1792166030305,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-037 -127"],"award-info":[{"award-number":["109-2314-B-037 -127"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH111-1R19"],"award-info":[{"award-number":["KMUH111-1R19"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cmi.2024.03.023","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T09:27:13Z","timestamp":1711186033000},"page":"945-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The impact of the fluconazole trailing effect on the persistence of Candida albicans bloodstream infection when treated with fluconazole"],"prefix":"10.1016","volume":"30","author":[{"given":"Shang-Yi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Li","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tun-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Pin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.03.023_bib1","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00134-020-06240-x","article-title":"Invasive candidiasis in critical care: challenges and future directions","volume":"46","author":"Logan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2024.03.023_bib2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.03.023_bib3","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.cmi.2020.01.029","article-title":"Usefulness of EQUAL Candida Score for predicting outcomes in patients with candidaemia: a retrospective cohort study","volume":"26","author":"Huang","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.03.023_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/jiaa502","article-title":"Invasive candidiasis species distribution and trends, United States, 2009\u20132017","volume":"223","author":"Ricotta","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.cmi.2024.03.023_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID\u2217 guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.03.023_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.03.023_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/myc.13191","article-title":"Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection","volume":"64","author":"Levinson","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2024.03.023_bib8","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.03.023_bib9","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","article-title":"Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2024.03.023_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug resistance and tolerance in fungi","volume":"18","author":"Berman","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2024.03.023_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","author":"Delarze","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cmi.2024.03.023_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/mmy\/myw033","article-title":"Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates","volume":"54","author":"Marcos-Zambrano","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2024.03.023_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01624-18","article-title":"Implications of the EUCAST trailing phenomenon in Candida tropicalis for the in\u00a0vivo susceptibility in invertebrate and murine models","volume":"62","author":"Astvad","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.03.023_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.42.1.129","article-title":"Optimizing the correlation between results of testing in\u00a0vitro and therapeutic outcome in\u00a0vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis","volume":"42","author":"Rex","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.03.023_bib15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/mmy\/myy130","article-title":"The prevalence and clinical significance of microcolonies when tested according to contemporary interpretive breakpoints for fluconazole against Candida species using E-test","volume":"57","author":"Hauzer","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2024.03.023_bib16","doi-asserted-by":"crossref","first-page":"49 e1","DOI":"10.1016\/j.cmi.2016.09.016","article-title":"Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia","volume":"23","author":"Rueda","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.03.023_bib17","author":"Arendrup"},{"key":"10.1016\/j.cmi.2024.03.023_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00480-20","article-title":"Candida albicans genetic background influences mean and heterogeneity of drug responses and genome stability during evolution in fluconazole","volume":"5","author":"Gerstein","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.cmi.2024.03.023_bib19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2024.03.023_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cmi.2015.07.005","article-title":"Differential association of fluconazole dose and dose\/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection","volume":"21","author":"Brosh-Nissimov","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.03.023_bib21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10096-019-03611-1","article-title":"The association between fluconazole dose and MIC with mortality and persistence in candidemia","volume":"38","author":"Ghanem-Zoubi","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.03.023_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/myc.13085","article-title":"Persistent vs non-persistent candidaemia in adult patients in 2007\u20132016: a retrospective cohort study","volume":"63","author":"Ala-Houhala","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2024.03.023_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/mmy.39.1.35.40","article-title":"Reliability of clinical research on invasive fungal infections: a systematic review of the literature","volume":"39","author":"Ascioglu","year":"2001","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2024.03.023_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","article-title":"Persistent candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era","volume":"38","author":"Agnelli","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.03.023_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","article-title":"The trailing end point phenotype in antifungal susceptibility testing is pH dependent","volume":"43","author":"Marr","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.03.023_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1469-0691.2008.01956.x","article-title":"Factors influencing the trailing endpoint observed in Candida albicans susceptibility testing using the CLSI procedure","volume":"14","author":"Coenye","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.03.023_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1439-0507.2009.01739.x","article-title":"Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype","volume":"53","author":"Alp","year":"2010","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2024.03.023_bib28","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.46.8.2477-2481.2002","volume":"46","author":"Arthington-Skaggs","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.03.023_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1439-0507.2006.01329.x","article-title":"Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study","volume":"50","author":"Lee","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2024.03.023_bib30","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","article-title":"Quantitation of Candida albicans ergosterol content improves the correlation between in\u00a0vitro antifungal susceptibility test results and in\u00a0vivo outcome after fluconazole treatment in a murine model of invasive candidiasis","volume":"44","author":"Arthington-Skaggs","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2400154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2400154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:04:38Z","timestamp":1751371478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2400154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1198743X2400154X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.03.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of the fluconazole trailing effect on the persistence of Candida albicans bloodstream infection when treated with fluconazole","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}